Bank of New York Mellon
KRTX

Bank of New York Mellon’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Bank of New York Mellon’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-201,828
Closed -$63.9M – 4361
2023
Q4 		$63.9M Sell
201,828
-8,237
-4% -$1.6M 0.01% 892
2023
Q3 		$35.5M Buy
210,065
+7,464
+4% +$1.4M 0.01% 1197
2023
Q2 		$43.9M Sell
202,601
-17,301
-8% -$3.71M 0.01% 1097
2023
Q1 		$39.9M Buy
219,902
+3,504
+2% +$670K 0.01% 1148
2022
Q4 		$42.5M Sell
216,398
-2,404
-1% -$515K 0.01% 1099
2022
Q3 		$49.2M Sell
218,802
-45,537
-17% -$9.22M 0.01% 967
2022
Q2 		$33.4M Buy
264,339
+52,661
+25% +$6.05M 0.01% 1224
2022
Q1 		$26.8M Buy
211,678
+120,709
+133% +$13.6M 0.01% 1484
2021
Q4 		$11.9M Buy
90,969
+1,530
+2% +$198K ﹤0.01% 2007
2021
Q3 		$10.9M Buy
89,439
+8,122
+10% +$938K ﹤0.01% 2069
2021
Q2 		$9.27M Buy
81,317
+20,239
+33% +$2.37M ﹤0.01% 2184
2021
Q1 		$7.34M Sell
61,078
-3,791
-6% -$429K ﹤0.01% 2262
2020
Q4 		$6.59M Sell
64,869
-1,738
-3% -$161K ﹤0.01% 2229
2020
Q3 		$5.15M Sell
66,607
-5,198
-7% -$443K ﹤0.01% 2203
2020
Q2 		$8M Buy
71,805
+16,497
+30% +$1.43M ﹤0.01% 1963
2020
Q1 		$3.98M Buy
55,308
+15,508
+39% +$1.33M ﹤0.01% 2189
2019
Q4 		$3M Buy
39,800
+28,149
+242% +$1.23M ﹤0.01% 2595
2019
Q3 		$190K Buy
+11,651
New +$226K ﹤0.01% 3915

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Bank of New York Mellon's KRTX Position: Q1 2024 in Review

Bank of New York Mellon sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 201,828 shares — an estimated $63.9M sold.

Bank of New York Mellon first reported a position in KRTX in Q3 2019 and held it in 18 quarters. The position peaked at $63.9M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Bank of New York Mellon reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Bank of New York Mellon sold 201,828 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $63.9M.
  • Bank of New York Mellon first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2019 and held it in 18 quarters.
  • Bank of New York Mellon's Karuna Therapeutics, Inc. Common Stock position peaked at $63.9M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Bank of New York Mellon's 13F filing for Q1 2024, filed 25 Apr 2024.